Concepedia

Publication | Open Access

Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer

DOIFull Paper Access

259

Citations

27

References

2018

Year

Tilly Varughese, Ying Taur, Nina Cohen, M. Lia Palomba, Susan K. Seo, Tobias M. Hohl, Gil Redelman‐Sidi
Clinical Infectious Diseases

Abstract

Patients with lymphoid cancer receiving ibrutinib treatment are at risk for serious infections, including IFIs.

References

YearCitations

Page 1